Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market: Key Factor Driving The Growth In The Peptide Antibiotics Market

The Peptide Antibiotics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Peptide Antibiotics Market Size During the Forecast Period?
In recent times, the market size for peptide antibiotics has experienced a surge and its size is projected to elevate from $5.25 billion in 2024 to $5.82 billion by 2025, growing at a Compound Annual Growth Rate (CAGR) of 10.8%. The expansion throughout the previous period is a result of studies and development of peptide antibiotics, an enhancement in antibiotic resistance, an uplift in the prevalence of infectious diseases, advancements in peptide synthesis technologies, and the expansion of the pharmaceutical industry.

In the coming years, the peptide antibiotics market is predicted to experience robust growth. This market is projected to reach $8.47 billion by the year 2029, growing at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth during the forecast period could be due to a focus on the development of new antibiotics, a rise in antibiotic-resistant infections globally, enhancement of research and development in antimicrobial peptides, and regulatory backing for new antibiotic approvals. The forecast period is expected to witness major trends like the exploration of natural sources for antimicrobial peptides, the use of peptide antibiotics in animal healthcare, emphasis on peptide engineering for increasing efficaciousness, the development of combination peptide antibiotics, and the application of artificial intelligence and machine learning in peptide antibiotic discovery.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780

What Are the High-Growth Segments in the Peptide Antibiotics Market?
The peptide antibiotics market covered in this report is segmented -

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Key Drivers Are Expected to Influence Future Peptide Antibiotics Market Growth?
The prevalence of various infectious diseases is on the rise, which is expected to fuel the growth of the peptide antibiotics market. These diseases are brought on by hazardous micro-organisms like bacteria, fungi, parasites, among others. The increase in infectious diseases is majorly due to factors such as rapid urbanization, climate changes, and an escalated risk of emergent diseases, all contributing to the growing need for peptide antibiotics. These antibiotics work by breaking down the cell membranes, reinforcing their antibacterial action. To illustrate, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that in the America region, dengue cases had already exceeded seven million by April 2024, a stark increase from the 4.6 million cases reported for the entire 2023. Consequently, the rising rate of infectious diseases is driving the growth of the peptide antibiotics market.

Which Companies Hold the Largest Share Across Different Peptide Antibiotics Market Segments?
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

What Trends Are Driving Growth in The Peptide Antibiotics Market?
The peptide antibiotics market is witnessing a growing trend of strategic collaborations among major players. These partnerships aim to broaden their market reach and mutually benefit from each other's resources. Such an example is the collaboration between Berkeley Lights, an American digital cell biology firm, and Aanika Biosciences in January 2022. Aanika Biosciences plans to utilize Berkeley Lights' efficient and high-throughput screening services to quickly locate and improve functional antimicrobial peptides (AMPs), focused on eradicating harmful bacteria, particularly those implicated in foodborne illnesses. Additionally, the Beacon Optofluidic Platform will be employed to detect peptides detrimental to bacteria for developing an innovative antibacterial tag. This tag will then be integrated into their bacterial spore-based barcoding technology aimed at safeguarding the food supply chain. Aanika Biosciences is a biotech firm based in the USA.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

What Are the Emerging Geographies for The Peptide Antibiotics Market Growth?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peptide Antibiotics Market?
2. What is the CAGR expected in the Peptide Antibiotics Market?
3. What Are the Key Innovations Transforming the Peptide Antibiotics Industry?
4. Which Region Is Leading the Peptide Antibiotics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.